Compare RCAT & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCAT | MRVI |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2017 | 2020 |
| Metric | RCAT | MRVI |
|---|---|---|
| Price | $10.35 | $5.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $20.00 | $4.13 |
| AVG Volume (30 Days) | ★ 8.4M | 2.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | $17,836,382.00 | ★ $185,743,000.00 |
| Revenue This Year | $271.60 | $12.54 |
| Revenue Next Year | $41.21 | $7.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 79.95 | N/A |
| 52 Week Low | $5.77 | $2.29 |
| 52 Week High | $18.78 | $7.44 |
| Indicator | RCAT | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 61.78 | 37.18 |
| Support Level | $7.16 | $5.67 |
| Resistance Level | $11.74 | $6.55 |
| Average True Range (ATR) | 0.70 | 0.35 |
| MACD | 0.42 | -0.16 |
| Stochastic Oscillator | 86.19 | 24.71 |
Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Its suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities. The firm's Division includes Teal, FlightWave, and Blue Ops.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.